Pdt Partners, LLC 10x Genomics, Inc. Transaction History

Pdt Partners, LLC

$1.28 Billion
Q1 2025

A detailed history of Pdt Partners, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 659,040 shares of TXG stock, worth $9.23 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

659,040

Previous 354,958 85.67%

Holding current value

$9.23 Million

Previous $5.1 Million 12.87%

% of portfolio

0.45%

Previous 0.51%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$8.73 - $16.31 $2.65 Million - $4.96 Million	304,082 Added 85.67%	659,040 $5.75 Million
Q4 2024 Feb 14, 2025	BUY	$13.18 - $21.31 $2.99 Million - $4.83 Million	226,513 Added 176.35%	354,958 $5.1 Million
Q3 2024 Nov 14, 2024	SELL	$15.71 - $23.49 $2.1 Million - $3.13 Million	-133,435 Reduced 50.95%	128,445 $2.9 Million
Q2 2024 Aug 15, 2024	BUY	$19.45 - $37.37 $4.21 Million - $8.1 Million	216,662 Added 479.15%	261,880 $5.09 Million
Q1 2024 May 15, 2024	SELL	$36.08 - $54.3 $2.37 Million - $3.57 Million	-65,806 Reduced 59.27%	45,218 $1.7 Million
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $620,402 - $1.04 Million	18,077 Added 19.45%	111,024 $6.21 Million
Q3 2023 Nov 14, 2023	BUY	$40.86 - $62.98 $799,262 - $1.23 Million	19,561 Added 26.65%	92,947 $3.83 Million
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $5,554 - $6,400	-109 Reduced 0.15%	73,386 $4.1 Million
Q1 2023 May 15, 2023	BUY	$35.33 - $55.79 $2.6 Million - $4.1 Million	73,495 New	73,495 $4.1 Million
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $1.54 Million - $4.02 Million	-27,573 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $1.11 Million - $1.5 Million	-8,227 Reduced 22.98%	27,573 $4.11 Million
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $1 Million - $1.33 Million	6,900 Added 23.88%	35,800 $5.21 Million
Q2 2021 Aug 16, 2021	SELL	$134.22 - $202.37 $979,806 - $1.48 Million	-7,300 Reduced 20.17%	28,900 $5.66 Million
Q1 2021 May 17, 2021	SELL	$140.25 - $196.86 $869,690 - $1.22 Million	-6,201 Reduced 14.62%	36,200 $6.55 Million
Q4 2020 Feb 16, 2021	SELL	$126.47 - $163.7 $2.92 Million - $3.78 Million	-23,121 Reduced 35.29%	42,401 $6 Million
Q3 2020 Nov 16, 2020	SELL	$87.44 - $125.0 $1.34 Million - $1.92 Million	-15,378 Reduced 19.01%	65,522 $8.17 Million
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $4.72 Million - $7.23 Million	80,900 New	80,900 $7.23 Million

Others Institutions Holding TXG

# of Institutions

303

Shares Held

110M

Call Options Held

228K

Put Options Held

157K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.33B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account